Doctor profile · Federal record
Dr. Amanda Alberding, ANP
Family Nurse Practitioner (CMS: Nurse Practitioner) · South Bend, IN
- NPI 1346597630
- Accepts Medicare
- 14 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
211 N Eddy St
South Bend, IN 466173096
(574) 237-9231
Credentials & registration
- NPI registered
- August 2012 — 14 yrs on file
- Profile last updated
- April 18, 2019
- Year of graduation
- 2012 — 14 yrs since
- Specialty taxonomy
- 363LF0000X — NUCC code
- State license (1)
- Indiana #71004064A
- Medicaid
- IN #201230300
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1346597630. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
7,462
Distinct HCPCS
10
Medicare allowed
$180,391
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J7345 |
Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | 3,001 | 13 | $2 | |
17003 |
Destruction of precancer skin growth, 2-14 growths | 1,905 | 276 | $5 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 743 | 492 | $71 | |
17000 |
Destruction of precancer skin growth, 1 growth | 522 | 356 | $42 | |
11102 |
Biopsy of related skin growth, first growth | 335 | 269 | $76 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 230 | 174 | $45 | |
11103 |
Biopsy of related skin growth, each additional growth | 183 | 87 | $39 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 134 | 134 | $87 | |
17110 |
Destruction of skin growth, 1-14 growths | 107 | 79 | $89 | |
17004 |
Destruction of precancer skin growth, 15 or more growths | 78 | 59 | $132 |
In context: peer comparison
Among 46 peers in this city , average services per provider: 109. This provider delivers 68× the peer median.Open Payments
Industry payments received
All-time total
$742
Transactions
39
Manufacturers
14
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Janssen Biotech, Inc. | 4 | $196.62 | |
| ABBVIE INC. | 12 | $149.01 | |
| UCB, Inc. | 4 | $95.10 | |
| Novartis Pharmaceuticals Corporation | 4 | $74.15 | |
| E.R. Squibb & Sons, L.L.C. | 2 | $36.30 | |
| Regeneron Healthcare Solutions, Inc. | 1 | $35.70 | |
| Dermavant Sciences, Inc. | 2 | $30.27 | |
| Organon Llc | 1 | $25.00 | |
| GENZYME CORPORATION | 1 | $20.60 | |
| Smith+Nephew, Inc. | 1 | $17.83 | |
| Incyte Corporation | 1 | $16.96 | |
| GlaxoSmithKline, LLC. | 1 | $16.60 | |
| Amgen Inc. | 1 | $15.65 | |
| STRATA Skin Sciences, Inc. | 4 | $12.00 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
572
Patients
373
Total drug cost
$88,573
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Triamcinolone Acetonide | Generic | 122 | 80 | $1,564 |
| Doxycycline Monohydrate | Generic | 73 | 50 | $2,171 |
| Mupirocin | Generic | 61 | 45 | $548 |
| Hydrocortisone | Generic | 54 | 42 | $440 |
| Ketoconazole | Generic | 45 | 30 | $718 |
| Betamethasone Dipropionate | Generic | 36 | 25 | $2,266 |
| Fluocinonide | Generic | 27 | 19 | $1,427 |
| Fluorouracil | Generic | 27 | 25 | $2,824 |
| Metronidazole | Generic | 26 | 23 | $2,122 |
| Ciclopirox (Ciclopirox Olamine) | Brand | 25 | 20 | $903 |
Hospital affiliations
Frequently asked questions
What is Dr. Amanda Alberding's medical specialty?
Dr. Amanda Alberding practices Family Nurse Practitioner in South Bend, IN.
Where does Dr. Amanda Alberding practice?
Dr. Amanda Alberding practices at 211 N Eddy St, South Bend, IN 466173096. Office phone: 5742379231.
What is Dr. Amanda Alberding's NPI?
Dr. Amanda Alberding's National Provider Identifier (NPI) is 1346597630, issued by NPPES.
Does Dr. Amanda Alberding accept Medicare assignment?
Yes. Dr. Amanda Alberding accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Amanda Alberding commonly perform?
Top Medicare-reported procedures in 2023: Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg (HCPCS J7345); Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213). Source: CMS Medicare Physician & Other Practitioners file.